A deficit of brain dystrophin 71 impairs hypothalamic osmostat

Journal of Neuroscience Research

Volumn 88, Issue 2, 2010, Pages 324-334

  Benabdesselam, Roza ^a,b   Sene, Abdoulaye ^c   Raison, Danièle ^d   Benmessaoud Mesbah, Ouahiba ^a   Ayad, Ghazi ^b   Mornet, Dominique ^e   Yaffe, David ^f   Rendon, Alvaro ^c   Hardin Pouzet, Hélène ^d   Dorbani Mamine, Latifa ^b  

^a UNIVERSITÉ MOULOUD MAMMERI   (Algeria)

^b UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^c INSTITUT DE LA VISION   (France)

^d Groupe Enzymologie Moléculaire et Fonctionnelle   (France)

^e UNIV MONTPELLIER   (France)

^f WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Dp71; Neurohypophysis; Osmoregulation; Supraoptic nucleus; Vasopressin

Indexed keywords

BRAIN PROTEIN; DYSTROPHIN; DYSTROPHIN 140; DYSTROPHIN 71; GENE PRODUCT; MESSENGER RNA; UNCLASSIFIED DRUG; VASOPRESSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN FUNCTION; CELL INTERACTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE DISRUPTION; GIANT CELL; GLIA CELL; HORMONE DETERMINATION; HORMONE SYNTHESIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAGNOCELLULAR NUCLEUS; MALE; MOUSE; NERVE CELL; NEUROHYPOPHYSIS; NONHUMAN; OSMORECEPTOR; OSMOREGULATION; PLASMA OSMOLALITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; SALT LOADING; SUPRAOPTIC NUCLEUS; VASOPRESSIN RELEASE;

ANIMALS; BLOOD; BRAIN; DYSTROPHIN; HYPOTHALAMUS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PITUITARY GLAND, POSTERIOR; RNA, MESSENGER; SALTS; SUPRAOPTIC NUCLEUS; VASOPRESSINS; WATER; WATER-ELECTROLYTE BALANCE;

EID: 74049092764     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22198     Document Type: Article

References (45)

1. Alonso G. 1988. Effects of colchicine on the intraneuronal transport of secretory material prior to the axon: a morphofunctional study in hypothalamic neurosecretory neurons of the rat. Brain Res 453:191-203.
2. Arima H, Kondo K, Kakiya S, Nagasaki H, Yokoi H, Yambe Y, Murase T, Iwasaki Y, Oiso Y. 1999. Rapid and sensitive vasopressin heteronuclear RNA responses to changes in plasma osmolality. J Neuroendocrinol 11:337-341.
3. Austin RC, Morris GE, Howard PL, Klamut HJ, Ray PN. 2000. Expression and synthesis of alternatively spliced variants of Dp71 in adult human brain. Neuromusc Disord 10:187-193.
4. Blake DJ, Weir A, Newey SE, Davies KE. 2002. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82:291-329.
5. Bourque CW. 1998. Osmoregulation of vasopressin neurons: a synergy of intrinsic and synaptic processes. Prog Brain Res 119:59-76.
6. Brazeau GA, Mathew M, Entrikin RK. 1992. Serum and organ indices of the mdx dystrophic mouse. Res Commun Chem Pathol Pharmacol 77:179-189.
7. Dai WJ, Yao T. 1995. Effects of dehydration and salt-loading on hypothalamic vasopressin mRNA level in male and female rats. Brain Res 676:178-182.
8. Dalloz C, Sarig R, Fort P, Yaffe D, Bordais A, Pannicke T, Grosche J, Mornet D, Reichenbach A, Sahel J, Nudel U, Rendon A. 2003. Target inactivation of dystrophin gene product Dp71: phenotypic impact in mouse retina. Hum Mol Genet 13:1543-1554.
9. Esclapez M, Chang DK, Houser CR. 1996. Subpopulations of GABA neurons in the dentate gyrus express high levels of the alpha 1 subunit of the GABAA receptor. Hippocampus 6:225-238.
10. Fort P, Sene A, Pannicke T, Roux MJ, Forster V, Mornet D, Nudel U, Yaffe D, Reichenbach A, Sahel JA, Rendon A. 2008. Kir4.1 and AQP4aAssociate with Dp71- and utrophin-DAPs complexes in specific and defined microdomains of Muller retinal glial cell membrane. Glia 56:597-610.
11. Ghorbel MT, Sharman G, Hindmarch C, Becker KG, Barrett T, Murphy D. 2006. Microarray screening of supression subtractive hybridization-PCR cDNA libraries identifies novel RNAs regulated by dehydration in the rat supraoptic nucleus. Physiol Genom 24:163-172.
12. Gorecki DC, Barnard EA. 1995. Specific expression of G-dystrophin (Dp71) in the brain. Neuroreport 6:893-896.
13. 1H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue. Anal Biochem 293:16-21.
14. Griffin JL, Sang E, Evens T, Davies K, Clarke K. 2002. Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy. FEBS Lett 530:109-116.
15. Haenggi T, Fritschy JM. 2006. Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non muscle tissue. Cell Mol Life Sci 63:1614-1631.
16. Haenggi T, Soontornmalai A, Schaub MC, Fritschy JM. 2004. The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain. Neuroscience 129:403-413.
17. Hatton GI. 1997. Function-related plasticity in hypothalamus. Annu Rev Neurosci 20:375-397.
18. Hernandez-Gonzalez EO, Mornet D, Rendon A, Martinez-Rojas D. 2005. Absence of Dp71 in mdx3cv mouse spermatozoa alters flagellar morphology and the distribution of ion channels and nNOS. J Cell Sci 118:137-145.
19. Imamura M, Ozawa E. 1998. Differential expression of dystrophin isoforms and utrophin during dibutyryl-cAMP-induced morphological differentiation of rat brain astrocytes. Proc Natl Acad Sci U S A 95:6139-6144.
20. Jancsik V, Hajos F. 1999. The demonstration of immunoreactive dystrophin and its developmental expression in perivascular astrocytes. Brain Res 831:200-205.
21. Kim TW, Wu K, Xu JL, Black IB. 1992. Detection of dystrophin in the postsynaptic density of rat brain and deficiency in a mouse model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 89:11642-11644.
22. Kondo N, Arima H, Banno R, Kuwahara S, Sato I, Oiso Y. 2004. Osmoregulation of vasopressin release and gene transcription under acute and chronic hypovolemia in rats. Am J Physiol Endocrinol Metab 286:E337-E346.
23. Lidov HG, Byers TL, Watkins SC, Kunkel LM. 1990. Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature 348:725-728.
24. Loufrani L, Matrougui K, Gorny D, Duriez M, Blanc I, Levy BI, Henrion D. 2001. Flow (shear stress)-induced endothelium-dependant dilatation is altered in mice lacking the gene encoding for dystrophin. Circulation 103:864-870.
25. Matsumara K, Campbell KP. 1994. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17:2-15.
26. Matsunaga W, Miyata S, Kiyohara T. 1999. Redistribution of MAP2 immunoreactivity in the neurohypophysial astrocytes of adult rats during dehydration. Brain Res 829:7-17.
27. McKinley MJ, Mathai ML, McAllen RM, McClear RC, Miselis RR, Pennington GL, Vivas L, Wade JD, Oldfield BJ. 2004. Vasopressin: osmotic and hormonal regulation by the lamina terminalis. J Neuroendocrinol 16:340-347.
28. Miller M, Moses AM. 1971. Radioimmunoassay of urinary antidiuretic hormone with application to study of the Brattleboro rat. Endocrinology 88:1389-1396.
29. Nico B, Frigeri A, Nicchia GP, Corsi P, Ribatti D, Quondamatteo F, Herken R, Girolamo F, Marzullo A, Svelto M, Roncali L. 2003. Severe alterations of endothelial and glial in the blood-brain barrier of dystrophic mdx mice. Glia 42:235-251.
30. Rae C, Griffin JL, Blair DH, Bothwell JH, Bubb WA, Maitland A, Head S. 2002. Abnormalities in brain biochemistry associated with lack of dystrophin: studies of the mdx mouse. Neuromusc Disord 12:121-129.
31. Robert FR, Léon-Henri BP, Chapleur-Chateau MM, Girr MN, Burlet AJ. 1985. Comparison of three immunoassays in the screening and characterization of monoclonal antibodies against arginine-vasopressin. J Neuroimmunol 9:205-220.
32. Rosso L, Mienville JM. 2009. Pituicyte modulation of neurohormone output. Glia 57:235-243.
33. Royuela M, Chazalette D, Hugon G, Paniagua R, Guerlavais F, Fehrentz JA, Martinez J, Labbe JP, Rivier F, Mornet D. 2003. Formation of multiple complexes between b-dystroglycan and dystrophin family products. J Muscle Res Cell Motil 24:387-397.
34. Sarig R, Mezger-Lallemand V, Gitelman I, Davis C, Fuchs O, Yaffe D, Nudel U. 1999. Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development. Hum Mol Genet 8:1-10.
35. Schofield JN, Blake DJ, Simmons C, Morris GE, Tinsley JM, Davies KE, Edwards YH. 1994. Apodystrophin-1 and apodystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines. Hum Mol Genet 3:1309-1316.
36. Sheng M, Wyszynski M. 1997. Ion channel targeting in neurons. Bioessays 19:847-853.
37. Shumyatcher Y, Shah TA, Noritz GH, Brouhard BH, Spirnak JP, Birnkrant DJ. 2008. Symptomatic nephrolithiasis in prolonged survivors of Duchenne muscular dystrophy. Neuromusc Disord 18:561-564.
38. Singh M, Jacobs IB, Spirnak JP. 2007. Nephrolithiasis in patients with Duchenne muscular dystrophy. Urology 70:643-645.
39. Stuhrmann M, Heilbronner H, Reis A, Wegner RD, Fischer P, Schmidtke J. 1991. Characterization of a Xp21 microdeletion syndrome in a 2 year-old boy with muscular dystrophy, glycerol kinase deficiency and adrenal hypoplasia congenita. Hum Genet 86:414-415.
40. Theodosis DT. 2002. Oxytocin-secreting neurons: a physiological model of morphological neuronal and glial plasticity in the adult hypothalamus. Front Neuroendocrinol 23:101-135.
41. Trembleau A, Roche D, Calas A. 1993. Combination of non-radioactive and radioactive in situ hybridization with immunohistochemistry: a new method allowing the simultaneous detection of two mRNAs and one antigen in the same brain tissue section. J Histochem Cytochem 41:489-498.
42. Tweedle CD, Hatton GI. 1987. Morphological adaptability at neurosecretory axonal endings on the neurovascular contact zone of the rat neurohypophysis. Neuroscience 20:241-246.
43. Vacher CM, Frétier P, Créminon C, Calas A, Hardin-Pouzet H. 2002. Activation by serotonin and noradrenaline of vasopressin and oxytocin expression in the mouse paraventricular and supraoptic nuclei. J Neurosc 22:1513-1522.
44. Yanagisawa A, Yokota N, Miyagawa M, Kawamura J, Ishihara T, Aoyagi T, Ishikawa K. 1990. Plasma levels of atrial natriuretic peptide in patients with Duchenne's progressive muscular dystrophy. Am Heart J 120:1154-1158.
45. Zhang Z, Bourque CW. 2003. Osmosensory neurons. Nat Neurosci 6:1021-1022.